Ozone therapy restores immune dysfunction in refractory idiopathic granulomatous mastitis as a novel potential therapeutic approach.
IFN-γ
IL-10
TGF-β
TNF-α
idiopathic granulomatous mastitis
ozone therapy
Journal
Cell biology international
ISSN: 1095-8355
Titre abrégé: Cell Biol Int
Pays: England
ID NLM: 9307129
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
14
08
2022
accepted:
20
09
2022
pubmed:
16
11
2022
medline:
22
12
2022
entrez:
15
11
2022
Statut:
ppublish
Résumé
Immunological dysfunction has been suggested to play a major role in the pathogenesis of idiopathic granulomatous mastitis (IGM). We recently showed that ozone therapy was effective in patients with steroid-resistant IGM. This study assessed alterations in intracellular cytokine expression patterns in different T-lymphocyte subsets after ozone therapy in refractory IGM. Peripheral blood T lymphocyte subsets (CD8
Substances chimiques
Cytokines
0
Interleukin-10
130068-27-8
Transforming Growth Factor beta
0
Tumor Necrosis Factor-alpha
0
Ozone
66H7ZZK23N
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
228-237Subventions
Organisme : Istanbul Breast Society
Informations de copyright
© 2022 International Federation for Cell Biology.
Références
Altintoprak, F., Karakece, E., Kivilcim, T., Dikicier, E., Cakmak, G., Celebi, F., & Ciftci, I. H. (2013). Idiopathic granulomatous mastitis: An autoimmune disease? The Scientific World Journal, 2013, 1-5. https://doi.org/10.1155/2013/148727
Asoglu, O., Ozmen, V., Karanlik, H., Tunaci, M., Cabioglu, N., Igci, A., Selcuk, U. E., & Kecer, M. (2005). Feasibility of surgical management in patients with granulomatous mastitis. The Breast Journal, 11(2), 108-114.
Ates, D., Doner, H. C., Kurban, S., & Koksal, H. (2021). The effect of soluble TREM-1 in idiopathic granulomatous mastitis. Immunological Investigations, 51, 839-850. https://doi.org/10.1080/08820139.2021.1879846
Baeza, J., Cabo, J. R., Gomez, M., Menendez, S., & Re, L. (2015). WFOTs reviews on evidence based ozone therapy. World Federation of Ozone therapy, 2, 116.
Bocci, V. (2005). Ozone: Chapter 9: The Cinical Application of Ozone Therapy. 1.1.5. Autoimmune diseases. Can Ozone Therapy do better than antibodies to TNF-α? A new medical drug (pp. 149-161). Springer.
Cabioglu, N., Trabulus, D. C., Yalcin, N., Emiroglu, S., Dinc, N., Tukenmez, M., & Güven, Y. I. (2021). The American Society of Breast Surgeon Official Proceedings. Vol 22. Annual Meeting Scientific Session Abstracts, p. 236, Abstract: 239; Poster presented at the 22nd Annual Meeting of the American Society of Breast Surgeons held virtually April 29-May 2, 2021.
Cetin, K., Sıkar, H. E., & Gulluoglu, B. M. (2020). Idiopathic granulomatous mastitis with erythema nodosum: Is it a variant of clinical presentation indicating treatment resistance? A retrospective cohort study. The Breast Journal, 26(9), 1645-1651. https://doi.org/10.1111/tbj.13944
Çolak, Ş., Genç Yavuz, B., Yavuz, M., Özçelik, B., Öner, M., Özgültekin, A., & Şenbayrak, S. (2021). Effectiveness of ozone therapy in addition to conventional treatment on mortality in patients with COVID-19. International Journal of Clinical Practice, 75, 1-7. https://doi.org/10.1111/ijcp.14321
Emsen, A., Köksal, H., Uçaryilmaz, H., Kadoglou, N., & Artaç, H. (2021). The alteration of lymphocyte subsets in idiopathic granulomatous mastitis. Turkish Journal of Medical Sciences, 51(4), 1905-1911. https://doi.org/10.3906/sag-2012-192.
Erhan, Y., Veral, A., Kara, E., Özdemir, N., Kapkac, M., Özdedeli, E., Yilmaz, R., Koyuncu, A., Erhan, Y., & Özbal, O. (2000). A clinicopthologic study of a rare clinical entity mimicking breast carcinoma: Idiopathic granulomatous mastitis. The Breast, 9(1), 52-56.
Erozgen, F., Ersoy, Y. E., Akaydin, M., Memmi, N., Celik, A. S., Celebi, F., Guzey, D., & Kaplan, R. (2010). Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma. Breast Cancer Research and Treatment, 123(2), 447-452.
Franzini, M., Valdenassi, L., Ricevuti, G., Chirumbolo, S., Depfenhart, M., Bertossi, D., & Tirelli, U. (2020). Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. International Immunopharmacology, 88, 106879. https://doi.org/10.1016/j.intimp.2020.106879
Izadi, M., Tahmasebi, S., Pustokhina, I., Yumashev, A. Y., Lakzaei, T., Alvanegh, A. G., & Ahmadi, M. (2020). Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients. Multiple Sclerosis and Related Disorders, 46, 102466. https://doi.org/10.1016/j.msard.2020.102466
Jiang, Q., Yang, G., Liu, Q., Wang, S., & Cui, D. (2021). Function and role of regulatory T cells in rheumatoid arthritis. Frontiers in Immunology, 12, 626193. https://doi.org/10.3389/fimmu.2021.626193
Karanlik, H., Ozgur, İ., Simsek, S., Fathalizadeh, A., Tukenmez, M., Sahin, D., Dursun, M., & Kurul, S. (2014). Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis? Breast Care, 9(5), 338-342.
Koksal, H. (2022). The clinical utility of autoantibodies in patients with idiopathic granulomatous mastitis. Journal of Investigative Surgery, 35(2), 325-329. https://doi.org/10.1080/08941939.2020.1861666
Koksal, H., Vatansev, H., Artac, H., & Kadoglou, N. (2020). The clinical value of interleukins-8, −10, and −17 in idiopathic granulomatous mastitis. Clinical Rheumatology, 39(5), 1671-1677.
Kundaktepe, B. P., Velidedeoglu, M., & Mete, B. (2022). The effect of methotrexate monotherapy on treatment-resistant idiopathic granulomatous mastitis patients. The Surgeon, 20(21), e13-e19. https://doi.org/10.1016/j.surge.2021.03.001
Lei, X., Chen, K., Zhu, L., Song, E., Su, F., & Li, S. (2017). Treatments for idiopathic granulomatous mastitis: Systematic review and meta-analysis. Breastfeeding Medicine, 12(7), 415-421.
Luo, W., Xu, B., Wang, L., Xiang, L., Lai, M., Zhang, X., & Liu, X. (2021). Clinical characteristics and predictive factors of erythema nodosum in granulomatous lobular mastitis. Australasian Journal of Dermatology, 62(3), 342-346. https://doi.org/10.1111/ajd.13640
Ma, X., Min, X., & Yao, C. (2020). Different treatments for granulomatous lobular mastitis: A systematic review and Meta-Analysis. Breast Care, 15(1), 60-66.
Machura, E., Mazur, B., Pieniążek, W., & Karczewska, K. (2008). Expression of naive/memory (CD45RA/CD45RO) markers by peripheral blood CD4+ and CD8 + T cells in children with asthma. Archivum Immunologiae et Therapiae Experimentalis, 56(1), 55-62. https://doi.org/10.1007/s00005-008-0005-6
Miyara, M., & Sakaguchi, S. (2011). Human FoxP3(+) CD4(+) regulatory T cells: Their knowns and unknowns. Immunology & Cell Biology, 89(3), 346-351. https://doi.org/10.1038/icb.2010.137
Mizrakli, T., Velidedeoglu, M., Yemisen, M., Mete, B., Kilic, F., Yilmaz, H., Ozturk, T., Ozaras, R., Aydogan, F., & Perek, A. (2015). Corticosteroid treatment in the management of idiopathic granulomatous mastitis to avoid unnecessary surgery. Surgery Today, 45(4), 457-465.
Ohtsuka, H., Ogata, A., Terasaki, N., Koiwa, M., & Kawamura, S. (2006). Changes in leukocyte population after ozonated autohemoadministration in cows with inflammatory disease. Journal of Veterinary Medical Science, 68(2), 175-178. https://doi.org/10.1292/jvms.68
Özel, L., Ünal, A., Ünal, E., Kara, M., Erdoğdu, E., Krand, O., Güneş, P., Karagül, H., Demiral, S., & Izzet Titiz, M. (2012). Granulomatous mastitis: Is it an autoimmune disease? Diagnostic and therapeutic dilemmas. Surgery Today, 42(8), 729-733.
Saydam, M., Yilmaz, K. B., Sahin, M., Yanik, H., Akinci, M., Yilmaz, I., Balas, S., Azili, C., & Gulcelik, M. A. (2020). New findings on autoimmune etiology of idiopathic granulomatous mastitis: Serum IL-17, IL-22 and IL-23 levels of patients. Journal of Investigative Surgery, 34, 993-997. https://doi.org/10.1080/08941939.2020.1725190
Tahmasebi, S., Qasim, M. T., Krivenkova, M. V., Zekiy, A. O., Thangavelu, L., Aravindhan, S., Izadi, M., Jadidi-Niaragh, F., Ghaebi, M., Aslani, S., Aghebat-Maleki, L., Ahmadi, M., & Roshangar, L. (2021). The effects of oxygen-ozone therapy on regulatory T-cell responses in multiple sclerosis patients. Cell Biology International, 45(7), 1498-1509. https://doi.org/10.1002/cbin.11589
Ucaryilmaz, H., Koksal, H., Emsen, A., Kadoglou, N., Dixon, J. M., & Artac, H. (2020). The role of regulatory T and B cells in the etiopathogenesis of idiopathic granulomatous mastitis. Immunological Investigations, 9, 1-11.
Vaillant, J. D., Fraga, A., Díaz, M. T., Mallok, A., Viebahn-Hänsler, R., Fahmy, Z., Barberá, A., Delgado, L., Menéndez, S., & Fernández, O. S. L. (2013). Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats. European Journal of Pharmacology, 714(1-3), 318-324. https://doi.org/10.1016/j.ejphar.2013.07.034
Wang, H., Daniel, V., Sadeghi, M., & Opelz, G. (2013). Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: Comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation. Transplantation Proceedings, 45(5), 1822-1831. https://doi.org/10.1016/j.transproceed.2012.10.061
Wolfrum, A., Kümmel, S., Theuerkauf, I., Pelz, E., & Reinisch, M. (2018). Granulomatous mastitis: A therapeutic and diagnostic challenge. Breast Care, 13, 413-418.